Darbepoetin Alfa Reduces RBC Transfusions in Infants with HDFN Treated with Intrauterine Transfusions Hemolytic disease of the fetus and newborn (HDFN) is a severe disorder caused by maternal antibodies against fetal RBC antigens… December 6, 2023
Restrictive or Liberal Transfusion Thresholds for Patients with Myocardial Infarctions While restrictive transfusion thresholds are beneficial for most patients and reduce blood use by 50%, but transfusion guidelines state there… November 15, 2023
Small-Volume Blood Collection Tubes Reduce Transfusion Patients in the intensive care unit (ICU) often have multiple blood draws daily, which typically amount to approximately one… November 1, 2023
High Variability in ICU Transfusion Practices Globally The International Point Prevalence Study of Intensive Care Unit Transfusion Practices (InPUT) is a prospective cohort study that included 3643… October 18, 2023
AABB Clinical Practice Guidelines for RBC Transfusions The AABB has updated their clinical practice guidelines regarding RBC transfusion thresholds. The guidelines are based on data from 45… October 12, 2023
Pathogen-Reduced Platelet Use and Overall Blood Product Cost Increased Since 1997, the biennial Department of Health and Human Services’ National Blood and Collection Utilization Survey (NBCUS) has been used… September 27, 2023
Intravenous Iron plus Tranexamic Acid for Patients Undergoing Surgery for Hip Fractures Hip fractures are common in older adults, and mortality from hip fractures is approximately 3-5% in the hospital and increases… August 23, 2023
Donor Age, Sex, and Hemoglobin Levels Associated with RBC Transfusion Effectiveness in Very Low Birth Weight Infants About half of very low birth weight (VLBW) infants (<1500 g at birth) require blood transfusions to manage anemia. To… August 16, 2023
Consensus Definition for Massive Transfusion? Severe bleeding is commonly encountered in surgery, trauma, gastrointestinal hemorrhage and obstetrics and may require massive transfusion (MT). A universal… July 20, 2023
Luspatercept versus Epoetin Alfa for Lower-Risk Myelodysplastic Syndrome Myelodysplastic syndromes (MDS) are caused by a heterogeneous group of hematopoietic stem cell disorders and can progress to acute myeloid… July 12, 2023
RBC Transfusion